Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236297 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
The therapeutic margin for nasopharyngeal carcinoma is extremely narrow, and a significant increase in brain necrosis could result from dose escalation. The significant factors affecting the risk of deafness included age, concurrent chemoradiotherapy, and greater radiation dose to the cochlea.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Anne W.M. F.R.C.R., W.T. F.R.C.R., W.M. C.M.D., M.Sc., C.W. M.Sc., Raymond B.Sc., Y.H. B.Sc., Peter T.C. B.Sc., T.K. F.R.C.R., Amy T.Y. M.B.B.S., Samuel K.C. M.Sc., Michael C.H. Ph.D., Soren M. Ph.D., D.Sc.,